The Technical Analyst
Apyx Medical Corp [APYX]
Exchange: NASDAQ Sector: Healthcare Industry: Medical Devices
Apyx Medical Corp Price, Forecast, Insider, Ratings, Fundamentals & Signals
-4.35% $1.320
America/New_York / 19 apr 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 45.73 mill |
| EPS: | -0.540 |
| P/E: | -2.44 |
| Earnings Date: | May 08, 2024 |
| SharesOutstanding: | 34.64 mill |
| Avg Daily Volume: | 0.158 mill |
| RATING 2024-04-19 |
|---|
| B+ |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Sell | |
| DE: | Strong Buy | |
| P/E: | Sell | |
| Price To Book: | Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -2.44 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -0.01x |
| Company: PE -2.44 | industry: PE 222.16 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 1.133 - 1.507 ( +/- 14.17%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-01-10 | Citronowicz Moshe | Buy | 72 000 | Stock Option (Option to Buy) |
| 2024-01-10 | Hornsby Todd | Buy | 100 000 | Stock Option (Option to Buy) |
| 2024-01-10 | Hill Matthew C | Buy | 150 000 | Stock Option (Option to Buy) |
| 2024-01-10 | Goodwin Charles D. Ii | Buy | 243 000 | Stock Option (Option to Buy) |
| 2023-12-12 | Hill Matthew C | Buy | 2 500 | Common Stock |
| INSIDER POWER |
|---|
| 68.08 |
| Last 99 transactions |
| Buy: 2 601 574 | Sell: 498 840 |
Forecast:
16:00 - $1.320
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $1.320
Forecast 2: 16:00 - $1.320
Forecast 3: 16:00 - $1.320
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $1.320 (-4.35% ) |
| Volume | 0.0568 mill |
| Avg. Vol. | 0.158 mill |
| % of Avg. Vol | 36.02 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For APYX
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
APYX
Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ablate soft tissue during open and laparoscopic surgical procedures. The company offers Renuvion branded products for the cosmetic surgery market that enable plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and J-Plasma branded products for the hospital surgical market. It also develops, manufactures, and sells disposable hand pieces, and OEM generators and accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
Latest Press Releases
2024-04-11 07:30:00 - Press Release
Apyx Medical Corporation Showcases New Data And Treatment Insights At The Renuvion® Users' Summit
Clearwater, fla.--(business wire)--apyx® medical corporation (nasdaq:apyx) (the “apyx medical”; “company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as renuvion®, is pleased to announce the renuvion users' summit is taking place in las vegas from april 12-13, 2024. the renuvion users' summit brings together a diverse group of dedicated professionals in cosmetic and plastic surgery from 13 countries to share new research, applications, and c.
2024-03-21 07:00:00 - Press Release
Apyx Medical Corporation Reports Fourth Quarter And Full Year 2023 Financial Results; Introduces Full Year 2024 Financial Outlook
Clearwater, fla.--(business wire)--apyx medical corporation (nasdaq:apyx) (“apyx medical;” the “company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as renuvion®, today reported financial results for its fourth quarter and full year ended december 31, 2023, and introduced financial expectations for the full year ending december 31, 2024. fourth quarter 2023 financial summary: total revenue of $14.7 million, an increase of 16% year-over-year.
2024-03-04 07:30:00 - Press Release
Apyx Medical Corporation To Release Fourth Quarter And Fiscal Year 2023 Financial Results On March 21, 2024
Clearwater, fla.--(business wire)--apyx® medical corporation (nasdaq:apyx) (the “company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as renuvion®, today announced that financial results for the fourth quarter and fiscal year 2023 will be released before the market opens on thursday, march 21st. management will host a conference call at 8:00 a.m. eastern time on march 21st to discuss the results of the quarter and year, and to host a questio.
2024-02-21 07:30:00 - Press Release
Apyx Medical Corporation Announces Renuvion To Be Featured In Educational Sessions At The American Academy Of Cosmetic Surgery (aacs) Scientific Meeting
Clearwater, fla.--(business wire)--apyx medical corporation (nasdaq: apyx) (“apyx medical;” the “company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as renuvion®, today announced that its renuvion technology will be featured in three educational sessions at the upcoming american academy of cosmetic surgery's 40th annual scientific meeting, to be held in new orleans, la from february 22 – 24. “apyx medical is pleased to see renuvion featured.
2024-01-22 07:30:00 - Press Release
Apyx Medical Corporation Announces Peer-reviewed Clinical Publication Evaluating The Safety Of Renuvion® Following Liposuction In Multiple Areas Of The Body
Clearwater, fla.--(business wire)--apyx medical corporation (nasdaq: apyx) (“apyx medical;” the “company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as renuvion®, today announced the publication of a peer-reviewed article in the aesthetic surgery journal open forum, which evaluated the use of renuvion for contracting subcutaneous soft tissue following liposuction in multiple areas of the body. “we are excited to see the publication of this.
Latest News
2024-03-21 10:12:10 - Seeking Alpha
Apyx Medical Corporation (APYX) Q4 2023 Earnings Call Transcript
2024-03-21 09:15:20 - Zacks Investment Research
Apyx Medical (APYX) Reports Q4 Loss, Tops Revenue Estimates
Apyx Medical (APYX) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to loss of $0.17 per share a year ago.
2024-03-04 07:30:00 - Business Wire
Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2023 Financial Results on March 21, 2024
CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx® Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today announced that financial results for the fourth quarter and fiscal year 2023 will be released before the market opens on Thursday, March 21st. Management will host a conference call at 8:00 a.m. Eastern Time on March 21st to discuss the results of the quarter and year, and to host a questio.
2023-11-09 11:30:06 - Seeking Alpha
Apyx Medical Corporation (APYX) Q3 2023 Earnings Call Transcript
Apyx Medical Corporation (NASDAQ:APYX ) Q3 2023 Earnings Conference Call November 9, 2023 8:00 AM ET Company Participants Charles Goodwin - President & CEO Tara Semb - CFO Conference Call Participants Frank Takkinen - Lake Street Capital Markets Matthew O'Brien - Piper Sandler Matt Hewitt - Craig-Hallum George Sellers - Stephens Dave Turkaly - JMP Securities Operator Please stand by. Hello, and welcome, ladies and gentlemen, to the Third Quarter of Fiscal Year 2023 Earnings Conference Call for Apyx Medical Corporation.
2023-10-26 11:23:16 - Zacks Investment Research
Are Medical Stocks Lagging Apyx Medical (APYX) This Year?
Here is how Apyx Medical (APYX) and CymaBay Therapeutics Inc. (CBAY) have performed compared to their sector so far this year.
2023-10-02 07:30:00 - Business Wire
Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2023 Financial Results on November 9, 2023
CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx® Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today announced that financial results for the third quarter of fiscal year 2023 will be released before the market opens on Thursday, November 9th. Management will host a conference call at 8:00 a.m. Eastern Time on November 9th to discuss the results of the quarter, and to host a question and a.
2023-08-12 12:09:10 - Seeking Alpha
Apyx Medical Corporation (APYX) Q2 2023 Earnings Call Transcript
Apyx Medical Corporation (NASDAQ:APYX ) Q2 2023 Earnings Conference Call August 1, 2023 5:00 PM ET Company Participants Charles Goodwin - President & CEO Tara Semb - CFO Conference Call Participants Matt Hewitt - Craig-Hallum Capital Group George Sellers - Stephens Frank Takkinen - Lake Street Capital Markets Operator Hello, and welcome, ladies and gentlemen, to the Second Quarter of Fiscal 2023 Earnings Conference Call for Apyx Medical Corporation. At this time, all participants have been placed in a listen-only mode.
2023-08-10 19:01:45 - Zacks Investment Research
Apyx Medical (APYX) Reports Q2 Loss, Misses Revenue Estimates
Apyx Medical (APYX) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to loss of $0.16 per share a year ago.
2023-05-16 11:25:57 - Zacks Investment Research
Is Apyx Medical (APYX) Stock Outpacing Its Medical Peers This Year?
Here is how Apyx Medical (APYX) and Haemonetics (HAE) have performed compared to their sector so far this year.
2023-05-11 10:21:13 - Seeking Alpha
Apyx Medical Corporation (APYX) Q1 2023 Earnings Call Transcript
Apyx Medical Corporation (NASDAQ:APYX ) Q1 2023 Earnings Conference Call May 11, 2023 8:00 AM ET Company Participants Charlie Goodwin - President & CEO Tara Semb - CFO Conference Call Participants Matthew O'Brien - Piper Sandler Matt Hewitt - Craig-Hallum Capital Group Operator Hello and welcome, ladies and gentlemen, to the First Quarter of Fiscal Year 2023 Earnings Conference Call for Apyx Medical Corporation. At this time, all participants have been placed in a listen-only mode.